181 related articles for article (PubMed ID: 25515904)
21. Cost-effectiveness of a herpes zoster vaccination program among the French elderly people.
Belchior E; Lévy-Bruhl D; Le Strat Y; Herida M
Hum Vaccin Immunother; 2016 Sep; 12(9):2378-82. PubMed ID: 27484158
[TBL] [Abstract][Full Text] [Related]
22. Economic burden of herpes zoster among skilled nursing facility residents in the United States.
Ma L; White RR; Narayanan S; Schmader KE
J Am Med Dir Assoc; 2012 Jan; 13(1):54-9. PubMed ID: 21450176
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006.
Jih JS; Chen YJ; Lin MW; Chen YC; Chen TJ; Huang YL; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
Acta Derm Venereol; 2009 Nov; 89(6):612-6. PubMed ID: 19997693
[TBL] [Abstract][Full Text] [Related]
24. The burden of herpes zoster and postherpetic neuralgia in the United States.
Weaver BA
J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S2-7. PubMed ID: 17488884
[TBL] [Abstract][Full Text] [Related]
25. Disease burden of herpes zoster in Korea.
Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
J Clin Virol; 2010 Apr; 47(4):325-9. PubMed ID: 20181512
[TBL] [Abstract][Full Text] [Related]
26. Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans.
Insinga RP; Itzler RF; Pellissier JM
Pharmacoeconomics; 2007; 25(2):155-69. PubMed ID: 17249857
[TBL] [Abstract][Full Text] [Related]
27. Detection of varicella zoster virus DNA and viral antigen in human eyes after herpes zoster ophthalmicus.
Wenkel H; Rummelt V; Fleckenstein B; Naumann GO
Ophthalmology; 1998 Jul; 105(7):1323-30. PubMed ID: 9663241
[TBL] [Abstract][Full Text] [Related]
28. Ocular complications and loss of vision due to herpes zoster ophthalmicus in patients with HIV infection and a comparison with HIV-negative patients.
Nithyanandam S; Joseph M; Stephen J
Int J STD AIDS; 2013 Feb; 24(2):106-9. PubMed ID: 23512510
[TBL] [Abstract][Full Text] [Related]
29. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
Goldman GS
Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242
[TBL] [Abstract][Full Text] [Related]
30. Hospitalizations realted to herpes zoster infection in the Canary Islands, Spain (2005-2014).
García-Rojas A; Gil-Prieto R; Núñez-Gallo DÁ; Matute-Cruz P; Gil-de-Miguel A
BMC Infect Dis; 2017 Aug; 17(1):586. PubMed ID: 28836951
[TBL] [Abstract][Full Text] [Related]
31. Herpes zoster ophthalmicus: the virus strikes back.
Karlin JD
Ann Ophthalmol; 1993 Jun; 25(6):208-15. PubMed ID: 8393312
[TBL] [Abstract][Full Text] [Related]
32. Cost of herpes zoster and herpes zoster-related complications among immunocompromised individuals.
Meyers JL; Candrilli SD; Rausch DA; Yan S; Patterson BJ; Levin MJ
Vaccine; 2018 Oct; 36(45):6810-6818. PubMed ID: 30249425
[TBL] [Abstract][Full Text] [Related]
33. Herpes Zoster Ophthalmicus Review and Prevention.
Davis AR; Sheppard J
Eye Contact Lens; 2019 Sep; 45(5):286-291. PubMed ID: 30844951
[TBL] [Abstract][Full Text] [Related]
34. Ocular findings in Japanese patients with varicella-zoster virus infection.
Yoshida M; Hayasaka S; Yamada T; Yanagisawa S; Hayasaka Y; Nakamura N; Mihara M
Ophthalmologica; 2005; 219(5):272-5. PubMed ID: 16123552
[TBL] [Abstract][Full Text] [Related]
35. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older.
Stein AN; Britt H; Harrison C; Conway EL; Cunningham A; Macintyre CR
Vaccine; 2009 Jan; 27(4):520-9. PubMed ID: 19027048
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era.
Lin F; Hadler JL
J Infect Dis; 2000 Jun; 181(6):1897-905. PubMed ID: 10837168
[TBL] [Abstract][Full Text] [Related]
37. Ocular manifestations in herpes zoster ophthalmicus.
Puri LR; Shrestha GB; Shah DN; Chaudhary M; Thakur A
Nepal J Ophthalmol; 2011; 3(2):165-71. PubMed ID: 21876592
[TBL] [Abstract][Full Text] [Related]
38. Central nervous system involvement after herpes zoster ophthalmicus.
Haargaard B; Lund-Andersen H; Milea D
Acta Ophthalmol; 2008 Nov; 86(7):806-9. PubMed ID: 18221497
[TBL] [Abstract][Full Text] [Related]
39. Herpes zoster: Burden of disease in France.
Gonzalez Chiappe S; Sarazin M; Turbelin C; Lasserre A; Pelat C; Bonmarin I; Chosidow O; Blanchon T; Hanslik T
Vaccine; 2010 Nov; 28(50):7933-8. PubMed ID: 20946861
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity.
Tran KD; Falcone MM; Choi DS; Goldhardt R; Karp CL; Davis JL; Galor A
Ophthalmology; 2016 Jul; 123(7):1469-75. PubMed ID: 27067924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
